Should I buy or sell Teleflex stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TFX shares. View TFX analyst ratings or view top-rated stocks .

What is Teleflex's stock price target for 2024?

10 Wall Street analysts have issued 12-month target prices for Teleflex's stock. Their TFX share price targets range from $221.00 to $293.00. On average, they predict the company's share price to reach $258.40 in the next year. This suggests a possible upside of 13.6% from the stock's current price. View analysts price targets for TFX or view top-rated stocks among Wall Street analysts .

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX stock has decreased by 8.8% and is now trading at $227.56. View the best growth stocks for 2023 here .

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024. View our TFX earnings forecast .

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, November, 2nd. The medical technology company reported $3.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.27 by $0.37. The medical technology company had revenue of $746.39 million for the quarter, compared to analysts' expectations of $734.80 million. Teleflex had a net margin of 13.65% and a trailing twelve-month return on equity of 15.52%.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, November 2nd. Investors of record on Wednesday, November 15th will be given a dividend of $0.34 per share on Friday, December 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Tuesday, November 14th. Read our dividend analysis for TFX .

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 15.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.80% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for TFX .

What ETFs hold Teleflex's stock?

ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV) , SPDR S&P Health Care Equipment ETF (XHE) , Invesco S&P 500 Equal Weight Health Care ETF (RYH) , Invesco S&P 500 Equal Weight Health Care ETF (RSPH) , iShares U.S. Medical Devices ETF (IHI) , Mid Cap US Equity Select ETF (RNMC) , T. Rowe Price Capital Appreciation Equity ETF (TCAF) and Global X Aging Population ETF (AGNG) .

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY23 earnings guidance on Thursday, November, 2nd. The company provided earnings per share guidance of $13.30-$13.50 for the period, compared to the consensus earnings per share estimate of $13.26.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com . Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA) , AbbVie (ABBV) , Johnson & Johnson (JNJ) , Alibaba Group (BABA) , Lam Research (LRCX) , ServiceNow (NOW) , QUALCOMM (QCOM) , Advanced Micro Devices (AMD) , Salesforce (CRM) and Cisco Systems (CSCO) .

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional investors include Morgan Stanley (6.00%), Wellington Management Group LLP (5.20%), Invesco Ltd. (1.32%), TD Asset Management Inc (1.03%), Northern Trust Corp (0.97%) and Bank of New York Mellon Corp (0.88%). Insiders that own company stock include Andrew A Krakauer , Cameron P Hicks , Liam Kelly , Stephen K MD Klasko, Stephen K MD Klasko , Stuart A Randle and Thomas E Powell . View institutional ownership trends .

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Teleflex Stock Price, News & Analysis (NYSE:TFX)

$227.56

-1.80 (-0.78%)

(As of 12/5/2023 ET)

Compare

Today's Range: $225.15
▼
$230.17
50-Day Range: $179.39
▼
$229.36
52-Week Range: $177.63
▼
$276.43

Volume: 203,816 shs
Average Volume: 306,316 shs
Market Capitalization: $10.70 billion

P/E Ratio: 26.68
Dividend Yield: 0.60%
Price Target: $258.40

Teleflex MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.60 Rating Score
Upside/Downside: 13.6% Upside
$258.40 Price Target
Short Interest: Healthy
2.53% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.53
Upright™ Environmental Score
News Sentiment: 0.76
Based on 16 Articles This Week
Insider Trading: Selling Shares
$3.11 M Sold Last Quarter
Proj. Earnings Growth: 3.50%
From $13.41 to $13.88 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.99 out of 5 stars

Medical Sector

31st out of 948 stocks

Surgical & Medical Instruments Industry

9th out of 82 stocks

3.3

Analyst's Opinion

Consensus Rating
Teleflex has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 6 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $258.40, Teleflex has a forecasted upside of 13.6% from its current price of $227.56.
Amount of Analyst Coverage
Teleflex has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
2.53% of the outstanding shares of Teleflex have been sold short.
Short Interest Ratio / Days to Cover
Teleflex has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Teleflex has recently decreased by 13.14%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
Teleflex has a dividend yield of 0.60%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Teleflex does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Teleflex is 15.94%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.80% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Teleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for Teleflex is -1.53.

3.2

News and Social Media Coverage

News Sentiment
Teleflex has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 16 news articles for Teleflex this week, compared to 5 articles on an average week.
Search Interest
4 people have searched for TFX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Teleflex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,109,622.00 in company stock.
Percentage Held by Insiders
Only 1.41% of the stock of Teleflex is held by insiders.
Percentage Held by Institutions
97.15% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Teleflex are expected to grow by 3.50% in the coming year, from $13.41 to $13.88 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Teleflex is 26.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 119.97.
Price to Earnings Ratio vs. Sector
The P/E ratio of Teleflex is 26.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 130.27.
Price to Earnings Growth Ratio
Teleflex has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Teleflex has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Teleflex Stock (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TFX Stock News Headlines

December 6, 2023 | finance.yahoo.com

Teleflex (TFX) Signs Peripheral Access Purchasing Deal With PINC

December 6, 2023 | americanbankingnews.com

Teleflex (NYSE:TFX) Stock Rating Upgraded by Morgan Stanley

December 6, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

December 4, 2023 | msn.com

Morgan Stanley Upgrades Teleflex (TFX)

December 4, 2023 | forbes.com

Should You Pick Teleflex Stock After 20% Gains This Month?

December 3, 2023 | finance.yahoo.com

Returns On Capital At Teleflex (NYSE:TFX) Have Stalled

December 3, 2023 | americanbankingnews.com

Thomas E. Powell Sells 13,952 Shares of Teleflex Incorporated (NYSE:TFX) Stock

December 3, 2023 | americanbankingnews.com

Q4 2023 EPS Estimates for Teleflex Incorporated Boosted by Zacks Research (NYSE:TFX)

December 6, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

November 30, 2023 | americanbankingnews.com

Teleflex (NYSE:TFX) Upgraded to Buy by StockNews.com

November 29, 2023 | benzinga.com

Teleflex Stock (NYSE:TFX) Dividends: History, Yield and Dates

November 22, 2023 | msn.com

Teleflex (TFX) Enrolls First Patient in ACCESS-MANTA Registry

November 16, 2023 | finance.yahoo.com

Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry

November 14, 2023 | finance.yahoo.com

Teleflex to Present at the 35th Annual Piper Sandler Healthcare Conference

November 14, 2023 | finance.yahoo.com

Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments

November 13, 2023 | finance.yahoo.com

Earnings growth of 0.9% over 3 years hasn't been enough to translate into positive returns for Teleflex (NYSE:TFX) shareholders

November 9, 2023 | benzinga.com

Teleflex's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

November 6, 2023 | finance.yahoo.com

Teleflex Incorporated (NYSE:TFX) Q3 2023 Earnings Call Transcript

November 4, 2023 | seekingalpha.com

Teleflex Incorporated 2023 Q3 - Results - Earnings Call Presentation

November 3, 2023 | benzinga.com

Teleflex Stock (NYSE:TFX), Analyst Ratings, Price Targets, Predictions

November 2, 2023 | msn.com

Stocks Finish Higher on Hopes the Fed’s Rate Hikes Are Done

November 2, 2023 | finance.yahoo.com

Q3 2023 Teleflex Inc Earnings Call

November 2, 2023 | msn.com

Stocks Climb on Hopes the Fed is Done Raising Interest Rates

November 2, 2023 | markets.businessinsider.com

Teleflex Gains 10% After Q3 Results Surpass Estimates

November 2, 2023 | finance.yahoo.com

Compared to Estimates, Teleflex (TFX) Q3 Earnings: A Look at Key Metrics

November 2, 2023 | finance.yahoo.com

Teleflex Inc (TFX) Reports 8.7% Revenue Growth in Q3 2023

November 2, 2023 | washingtonpost.com

Teleflex: Q3 Earnings Snapshot

See More Headlines

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 9/15 Dividend: 9/14/2023
Dividend Payable: 9/15/2023
Last Earnings: 11/02/2023
Ex-Dividend for 12/15 Dividend: 11/14/2023
Today: 12/06/2023
Dividend Payable: 12/15/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/22/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:TFX
CUSIP: 87936910
CIK: 96943
Web: www.teleflex.com
Phone: (610) 225-6800
Fax: 215-553-5402
Employees: 15,500
Year Founded: 1943

Price Target and Rating

Average Stock Price Target: $258.40
High Stock Price Target: $293.00
Low Stock Price Target: $221.00
Potential Upside/Downside: +13.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.60
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $8.53
Trailing P/E Ratio: 26.68
Forward P/E Ratio: 16.97
P/E Growth: 2.43
Net Income: $363.14 million
Net Margins: 13.65%
Pretax Margin: 16.34%
Return on Equity: 15.52%
Return on Assets: 9.16%

Debt

Debt-to-Equity Ratio: 0.45
Current Ratio: 3.58
Quick Ratio: 2.51

Sales & Book Value

Annual Sales: $2.79 billion
Price / Sales: 3.83
Cash Flow: $18.16 per share
Price / Cash Flow: 12.53
Book Value: $85.74 per share
Price / Book: 2.65

Miscellaneous

Outstanding Shares: 47,000,000
Free Float: 46,337,000
Market Cap: $10.70 billion
Optionable: Optionable
Beta: 1.09

Social Links

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Liam J. Kelly (Age 56)
Chairman, President & CEO
Comp: $2M
Mr. Thomas E. Powell (Age 61)
Executive VP & CFO
Comp: $1.04M
Mr. Cameron P. Hicks (Age 58)
Corporate Vice President of Human Resources & Communications
Comp: $564.68k
Mr. Jay White (Age 49)
Corporate VP & President of Global Commercial
Comp: $866.86k
Mr. John R. Deren
Corporate VP & Chief Accounting Officer
Mr. Timothy F. Duffy
VP & Chief Information Officer
Mr. John Hsu C.F.A.
Vice President of Investor Relations
Mr. Daniel V. Logue (Age 49)
Corporate VP, General Counsel & Secretary
Mr. Howard Cyr
Corporate VP & Chief Compliance Officer
Mr. James Ferguson
President & GM of Surgical

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TFX Stock Analysis - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?: 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TFX shares.
View TFX analyst ratings or view top-rated stocks.
What is Teleflex's stock price target for 2024?: 10 Wall Street analysts have issued 12-month target prices for Teleflex's stock. Their TFX share price targets range from $221.00 to $293.00. On average, they predict the company's share price to reach $258.40 in the next year. This suggests a possible upside of 13.6% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.
How have TFX shares performed in 2023?: Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX stock has decreased by 8.8% and is now trading at $227.56.
View the best growth stocks for 2023 here.
When is Teleflex's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our TFX earnings forecast.
How were Teleflex's earnings last quarter?: Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, November, 2nd. The medical technology company reported $3.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.27 by $0.37. The medical technology company had revenue of $746.39 million for the quarter, compared to analysts' expectations of $734.80 million. Teleflex had a net margin of 13.65% and a trailing twelve-month return on equity of 15.52%.
How often does Teleflex pay dividends? What is the dividend yield for Teleflex?: Teleflex declared a quarterly dividend on Thursday, November 2nd. Investors of record on Wednesday, November 15th will be given a dividend of $0.34 per share on Friday, December 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Tuesday, November 14th.
Read our dividend analysis for TFX.
Is Teleflex a good dividend stock?: Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 15.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.80% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What ETFs hold Teleflex's stock?: ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), iShares U.S. Medical Devices ETF (IHI), Mid Cap US Equity Select ETF (RNMC), T. Rowe Price Capital Appreciation Equity ETF (TCAF) and Global X Aging Population ETF (AGNG).
What guidance has Teleflex issued on next quarter's earnings?: Teleflex issued an update on its FY23 earnings guidance on Thursday, November, 2nd. The company provided earnings per share guidance of $13.30-$13.50 for the period, compared to the consensus earnings per share estimate of $13.26.
What is Liam Kelly's approval rating as Teleflex's CEO?: 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Teleflex own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).
Who are Teleflex's major shareholders?: Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional investors include Morgan Stanley (6.00%), Wellington Management Group LLP (5.20%), Invesco Ltd. (1.32%), TD Asset Management Inc (1.03%), Northern Trust Corp (0.97%) and Bank of New York Mellon Corp (0.88%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends.
How do I buy shares of Teleflex?: Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:TFX) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Teleflex Stock Price, News & Analysis (NYSE:TFX)

Teleflex MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Teleflex Stock (NYSE:TFX)

TFX Stock Price History

TFX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

TFX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™